Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLeukemiaTeam Member asked a question 💭

I have Stage 3 CLL. I started treatment using Nemtabrutinib, a BTK-inhibitors, in December. The 65 mg daily pill lowered my blood pressure so much that I fainted once and had to lay down on the floor as I tried to walk from one room to another.

I am now on a 45 mg daily pill. Now my blood pressure is too high. My BP meds keep getting adjusted. I see my cardiologist this week and expect another adjustment.

The treatment has also caused my low platelets to go lower, 70 last week. A… read more

May 3
 · 
Reactions

Answer Summary

Members navigating CLL treatment connected over their experiences with BTK inhibitors, particularly the clinical trial drug Nemtabrutinib,... Read more

Members navigating CLL treatment connected over their experiences with BTK inhibitors, particularly the clinical trial drug Nemtabrutinib, sharing side effects like blood pressure changes, metallic taste, low platelets, and elevated white blood cell counts. Several members described practical ways they managed symptoms, including using Miralax for constipation, carefully monitoring blood pressure at home, and staying in close contact with their oncology teams through detailed symptom lists and trial nurse check-ins. A recurring theme was the value of staying informed and asking questions, with one member introducing the concept of absolute lymphocytes as an important marker in CLL that others hadn't heard of before.

A MyLeukemiaTeam Member

Donna, I was diagnosed with CLL in Dec 2024, though for about 6 mos the doctors suggested watch-and-wait. After my platelets got down to ~100, the doctor recommended treatment, and I entered the trial and was a lucky (?) winner, and I started with nemtabrutinib in Sept 2025. I have been taking 65 mg/day for most of this time.

I am lucky and have no symptoms from the CLL yet--I only know I have it because of blood tests. The nem (I'll call it that for short) has caused some minor symptoms, such as constipation and a metallic taste in my mouth. I've used Miralax for the former and the latter seems to have decreased over time (or I'm just getting used to it).

I have noticed my BP going up (I've NEVER had high BP in my life) and it's occasionally reached ~150/100, which prompted the doctor to take me off of nem for about a week in March. My BP seemed to drop immediately, and after 8 days I started the nem again (same dosage). I've watched my BP carefully since then and it fluctuates quite a bit, but seems to average 135/85 or so, which I think is acceptable to the docs.

My WBC went up immediately after starting nem, from ~100 in early Sep to over 350 (!) in Nov, and my platelets went down to ~60 by the end of Sep. But they eventually started in the right direction, and my WBC reached 107 in April and my platelets have hung around 130 or so since January.

I will see the oncologist again at the end of May and am hoping for continued progress. I still feel fine (69 yr-old male) and wouldn't know I had CLL if they didn't tell me.

I'm glad to know someone else taking nem. Please let me know how it goes--I'm pulling for you!

May 7
A MyLeukemiaTeam Member

Thanks. I do report to the Trial Nurse by text message and I also take a list of things that aren’t normal for me to my monthly appointments where I see either my oncologist or his Nurse Practitioner. They may be getting too much information from me - 😊

May 4
A MyLeukemiaTeam Member

The questions my oncologist had about my bloodwork did not revolve around my white count, but around my ling term (2 1/2 years) anemia and low platelet count. He ordered CT scans and a bone marrow biopsy with molecular analysis. It was the bone marrow biopsy results that resulted in a change in my CLL stage from Stage 1 to Stage 3.

May 9
A MyLeukemiaTeam Member

I don’t have any experience but maybe talk to your oncologist more about your side effects from it?

May 4
A MyLeukemiaTeam Member

Thanks for your outstanding report on a new BTK inhibitor. I had the high blood pressure ill affect with Brukinsa but finally the right medication has me 100% normal blood pressure. I have also developed a strange cough which is another ill affect. I stopped taking the drug and a month later the cough stopped. I now take Brukinsa at 50% dose or 160 mg and no cough and my blood test is 100% normal and WBC count is at 7,600. My question is the new medication covalent or non covalent? Covalent means it directly attaches to the cells. Non covalent means it "blocked" the attachment area. Both medications kill bad cells. I have a 9 minute view which explains these two different BTK inhibitors : https://cllsociety.org/btk-inhibitors-in-cll-sll/

BTK Inhibitors in CLL / SLL
BTK Inhibitors in CLL / SLL
May 3

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
Buffalo, NY

A MyLeukemiaTeam Member asked a question 💭
Wilmington, NC